Metabolomics and Microbiomics - Personalized Medicine from the Fetus to the Adult

Metabolomics and Microbiomics: Personalized Medicine from the Fetus to the Adult encompasses the most recent advances on the usage of metabolomics and microbiome research to improve disease diagnosis and healthcare. Medicine is changing from epidemiologic, descriptive, reductionist, and reactive approaches to individualized, predictive, and holistic ones by applying microbiomics to understand the functionality of the human body.
The book discusses topics such as systems biology approaches, omics technologies, perinatal programming, and personalized medicine. It also discusses the ethical implications of microbiomics research and new pathways of research, such as renal regenerative medicine, gender medicine in perinatology, and animals and the science of healing. The book is a valuable resource for medical professionals and researchers in metabolomics, nutrition, microbiology, and personalized-predictive medicine. The book also will appeal to non-specialized professionals who may take advantage of its captivating and simple language.

• Covers the latest scientific discoveries in order to improve health and early diagnosis of diseases
• Brings a holistic and perinatal programming approach-from fetus to adulthood-to early and long-term prevention of diseases
• Provides illustrations and diagrams to facilitate understanding for readers
• Discusses the ethical implications of microbiomics research and new pathways of research, such as renal regenerative medicine, gender medicine in perinatology, and animals and the science of healing

Vassilios Fanos, MD, is Postgraduate in Pediatrics, Neonatal Pathology and Intense Care, and Health Organization.
He is author of 20 books, 8 proceedings of congresses, and wrote 69 chapters for Italian and International publishing houses. He is guest editor of Curr Pharmac Design and Curr Med Chem. He has 336 scientific papers (Scopus, 303 on Pub Med). Dr. Fanos is editor-in-chief and founder of the Journal of Pediatric and Neonatal Individualized Medicine, board member of 10 journals (including J Chemother, World Journal of Obstetrics and Gynecology, Journal Maternal-Fetal Neonatal Medicine, World Journal of Clinical Pediatrics, Frontiers of Pathology, Frontiers in Neonatology, Journal of Urology & Research, Austin Journal of Pediatrics) and he is consultant referee of more than 40 international journals.
Dr. Fanos is investigator or co-investigator in research projects funded by public agencies (Veneto Region, Sardinia Region, University of Verona) or private agencies or pharmaceutical companies (Unicredit Bank, Fondazione Banco di Sardegna, Glaxo GSK, Marion Merrel Dow, Wellspring Corporation, Abbott, Danone, Byosinexus, Valeas) for a total of about 750.000 euros. Last grants: 198.000 euros from Italian Ministry of Health (first winner among 545 CMC projects) on metabolomics and sepsis. In 2013 he won a FP7 European Project with 6.000.000 euros on metabolomics and several grants ranging from 25.000 to 99.000 euros on metabolomics. His research focuses are Neonatology, nephrology, pharmacology, infections, laboratory medicine, and metabolomics